Cargando…

Ivabradine Ameliorates Kidney Fibrosis in L-NAME-Induced Hypertension

Hypertension-induced renal injury is characterized by structural kidney alterations and function deterioration. Therapeutics for kidney protection are limited, thus novel renoprotectives in hypertension are being continuously sought out. Ivabradine, an inhibitor of the I(f) current in the sinoatrial...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stanko, Peter, Baka, Tomas, Repova, Kristina, Aziriova, Silvia, Krajcirovicova, Kristina, Barta, Andrej, Janega, Pavol, Adamcova, Michaela, Paulis, Ludovit, Simko, Fedor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7365878/ https://www.ncbi.nlm.nih.gov/pubmed/32754607 http://dx.doi.org/10.3389/fmed.2020.00325

Ejemplares similares

Ivabradine improves survival and attenuates cardiac remodeling in isoproterenol‐induced myocardial injury
por: Simko, Fedor, et al.
Publicado: (2020)

Effect of Ivabradine on a Hypertensive Heart and the Renin-Angiotensin-Aldosterone System in L-NAME-Induced Hypertension
por: Simko, Fedor, et al.
Publicado: (2018)

Sacubitril/Valsartan and Ivabradine Attenuate Left Ventricular Remodelling and Dysfunction in Spontaneously Hypertensive Rats: Different Interactions with the Renin–Angiotensin–Aldosterone System
por: Simko, Fedor, et al.
Publicado: (2022)

Effect of Melatonin on the Renin-Angiotensin-Aldosterone System in l-NAME-Induced Hypertension
por: Simko, Fedor, et al.
Publicado: (2018)

Lactacystin-induced kidney fibrosis: Protection by melatonin and captopril
por: Repova, Kristina, et al.
Publicado: (2022)

Melatonin as a Potential Approach to Anxiety Treatment
por: Repova, Kristina, et al.
Publicado: (2022)

Cardiovascular therapeutics: A new potential for anxiety treatment?
por: Repova, Kristina, et al.
Publicado: (2022)

Hypertension and Cardiovascular Remodelling in Rats Exposed to Continuous Light: Protection by ACE-Inhibition and Melatonin
por: Simko, Fedor, et al.
Publicado: (2014)

Lactacystin-Induced Model of Hypertension in Rats: Effects of Melatonin and Captopril
por: Simko, Fedor, et al.
Publicado: (2017)

Renin–Angiotensin–Aldosterone System: Friend or Foe—The Matter of Balance. Insight on History, Therapeutic Implications and COVID-19 Interactions
por: Simko, Fedor, et al.
Publicado: (2021)

Ivabradine and Blood Pressure Reduction: Underlying Pleiotropic Mechanisms and Clinical Implications
por: Simko, Fedor, et al.
Publicado: (2021)

Peripheral and Central Effects of Melatonin on Blood Pressure Regulation
por: Pechanova, Olga, et al.
Publicado: (2014)

New Developments in the Pharmacological Treatment of Hypertension: Dead-End or a Glimmer at the Horizon?
por: Paulis, Ludovit, et al.
Publicado: (2015)

Angiotensin A/Alamandine/MrgD Axis: Another Clue to Understanding Cardiovascular Pathophysiology
por: Hrenak, Jaroslav, et al.
Publicado: (2016)

Melatonin as a rational alternative in the conservative treatment of resistant hypertension
por: Simko, Fedor, et al.
Publicado: (2019)

The Impact of microRNAs in Renin–Angiotensin-System-Induced Cardiac Remodelling
por: Adamcova, Michaela, et al.
Publicado: (2021)

Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: potential allies in the COVID-19 pandemic instead of a threat?
por: Simko, Fedor, et al.
Publicado: (2021)

Monitoring Non-dipping Heart Rate by Consumer-Grade Wrist-Worn Devices: An Avenue for Cardiovascular Risk Assessment in Hypertension
por: Baka, Tomas, et al.
Publicado: (2021)

Commentary: Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial Cells
por: Simko, Fedor, et al.
Publicado: (2022)

Chronotherapy of cardiovascular pathologies: a hopeful strategy
por: Simko, Fedor, et al.
Publicado: (2022)

Spice up the hypertension diet - curcumin and piperine prevent remodeling of aorta in experimental L-NAME induced hypertension
por: Hlavačková, Livia, et al.
Publicado: (2011)

The effect of zofenopril on the cardiovascular system of spontaneously hypertensive rats treated with the ACE2 inhibitor MLN-4760
por: Cacanyiova, Sona, et al.
Publicado: (2023)

Ivabradine in sepsis
por: Nair, Abhijit S, et al.
Publicado: (2013)

Hyperbilirubinemia Maintained by Chronic Supplementation of Unconjugated Bilirubin Improves the Clinical Course of Experimental Autoimmune Arthritis
por: Sykora, Tomas, et al.
Publicado: (2021)

Ivabradine and endothelium: an update
por: Dallapellegrina, Lucia, et al.
Publicado: (2020)

Ivabradine Ameliorates Cardiac Diastolic Dysfunction in Diabetic Mice Independent of Heart Rate Reduction
por: Xie, Hao, et al.
Publicado: (2021)

Effects of ivabradine hydrochloride combined with trimetazidine on myocardial fibrosis in rats with chronic heart failure
por: Ma, Dongwen, et al.
Publicado: (2019)

Ivabradine tolerability in heart failure
por: Birkhoelzer, Sarah, et al.
Publicado: (2018)

Initiation of ivabradine in cardiogenic shock
por: Chiu, Michael H., et al.
Publicado: (2019)

The Role of Ivabradine in the Management of Angina Pectoris
por: Giavarini, Alessandra, et al.
Publicado: (2016)

The Biological Effects of Ivabradine in Cardiovascular Disease
por: Speranza, Lorenza, et al.
Publicado: (2012)

Ivabradine: Lack of efficacy: case report
Publicado: (2021)

Ivabradine toxicity: a case report
por: Singh, Kavisha, et al.
Publicado: (2022)

Effects of Ivabradine on Left Ventricular Systolic Function and Cardiac Fibrosis in Rat Myocardial Ischemia-Reperfusion Model
por: Kim, Han Byul, et al.
Publicado: (2018)

Alternative RAS in Various Hypoxic Conditions: From Myocardial Infarction to COVID-19
por: Rajtik, Tomas, et al.
Publicado: (2021)

Ivabradine: the evidence of its therapeutic impact in angina
por: Marquis-Gravel, Guillaume, et al.
Publicado: (2008)

Advances in the management of heart failure: the role of ivabradine
por: Müller-Werdan, Ursula, et al.
Publicado: (2016)

Effectiveness of Ivabradine in Treating Stable Angina Pectoris
por: Ye, Liwen, et al.
Publicado: (2016)

Ivabradine for congenital junctional ectopic tachycardia in siblings
por: Kothari, Shyam S, et al.
Publicado: (2018)

Ivabradine for treatment of tachyarrhythmias in children and young adults
por: Janson, Christopher M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_s5kpsl7hfl6443t86d7q4at6km